Tag: large volume parenteral LVP global market report

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Large Volume Parenteral (LVP) Market Size, Value And Growth Trends Through 2030

The global market for large volume parenteral (LVP) solutions has experienced robust expansion lately. Projections indicate this sector will expand from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate of 9.1%. Key factors contributing to this growth during the preceding period include an upward trend in hospital admissions, increased reliance on intravenous fluid therapies, a rise in the number of surgical interventions, enhancements in critical care facilities, and advancements in managing infectious diseases.

The global market for large volume parenteral (LVP) solutions is poised for significant expansion, projected to reach $21.37 billion by the year 2030, registering a compound annual growth rate of 9.7% through the forecasted period. This upward trajectory is primarily fueled by an increasing elderly demographic, a higher incidence of long-term health conditions, a greater need for nutritional support via parenteral routes, the development of healthcare facilities in developing economies, and an increased provision of emergency and trauma medical services. Key developments shaping this market in the coming years include a surge in preference for environmentally friendly and PVC-free LVP containers, a greater availability of pre-prepared and mixed infusion products, an intensified emphasis on maintaining sterile conditions and preventing contamination, a broader application of LVPs in critical care settings and emergency medicine, and an overall increase in the volume of intravenous therapies administered within hospitals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Large Volume Parenteral (LVP) Market Expansion Supported By Key Demand Factors

The escalating incidence of long-term illnesses is anticipated to be a significant catalyst for the expansion of the large-volume parenteral market in the future. Chronic diseases, characterized by conditions persisting for three months or more and potentially progressing over time, are largely attributed to factors such as tobacco consumption, exposure to secondhand smoke, and inadequate dietary habits. Patients suffering from these ailments necessitate a balanced intake of vital nutrients essential for maintaining bodily strength, and parenteral administration proves advantageous by ensuring direct absorption of pharmaceutical dosages into the bloodstream, bypassing the digestive tract. Illustratively, the World Health Organization reported in September 2023 that non-communicable diseases, or chronic conditions, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Consequently, the increased prevalence of chronic diseases serves as a primary driver for the growth observed in the large-volume parenteral market.

Augmenting healthcare spending is projected to significantly boost the large-volume parenteral market in the coming period. This increase in financial investment towards healthcare encompasses a broader allocation of resources for medical services, research, and public health initiatives. Enhanced financial commitment often correlates with the development and fortification of healthcare infrastructure, including the establishment of new medical centers and facilities, thereby increasing the capacity for service delivery and consequently stimulating the demand for large-volume parenteral products. As an example, the American Medical Association indicated in April 2025 that US healthcare spending experienced a substantial rise of 7.5% in 2023, reaching $4.9 trillion or $14,570 per individual, a notable uptick from the 4.6% growth noted in the preceding year. Hence, the upward trend in healthcare expenditure is a key factor propelling the expansion of the large-volume parenteral market.

Large Volume Parenteral (LVP) Market Segment Landscape And Growth Potential

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Large Volume Parenteral (LVP) Market Growth Trends Influencing Competitive Dynamics

Global leaders in the large volume parenteral (LVP) market are prioritizing the creation of smart infusion device advancements, specifically intelligent large-volume infusion pumps, to address the growing need for enhanced safety, automation, and connectivity in intravenous therapy. This trend is fueled by the expansion of hospital-based infusion services, the rise of remote patient monitoring, and the industry-wide drive for standardized, error-minimizing medication administration. An intelligent large-volume infusion pump distinguishes itself from conventional devices by incorporating dose-error reduction software, smart drug library capabilities, and advanced alarm management, going beyond the manual programming and basic automation of older models. These sophisticated pumps are engineered to deliver substantial IV fluid volumes while actively preventing medication errors, easing healthcare professionals’ workloads, and seamlessly integrating with hospital information technology infrastructures. As a prime example, Baxter International Inc. secured U.S. FDA approval in April 2024 for its Novum IQ Large-Volume Infusion Pump, featuring the integrated Dose IQ smart-dose software. This innovative pump facilitates rapid fluid delivery, including extensive volume infusions, and boasts safety mechanisms like drug library integration to mitigate dosing inaccuracies, alongside the capability to link with hospital electronic health records and intelligent monitoring systems, ultimately empowering clinicians to enhance infusion precision, diminish the likelihood of dosage errors, and optimize workflows for high-volume IV therapies, ensuring safer and more efficient patient care.

Large Volume Parenteral (LVP) Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Access The Complete Large Volume Parenteral (LVP) Market Report:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Large Volume Parenteral (LVP) Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Large Volume Parenteral (LVP) Market Size, Value And Growth Trends Through 2030

The global market for large volume parenteral (LVP) solutions has experienced robust expansion lately. Projections indicate this sector will expand from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate of 9.1%. Key factors contributing to this growth during the preceding period include an upward trend in hospital admissions, increased reliance on intravenous fluid therapies, a rise in the number of surgical interventions, enhancements in critical care facilities, and advancements in managing infectious diseases.

The global market for large volume parenteral (LVP) solutions is poised for significant expansion, projected to reach $21.37 billion by the year 2030, registering a compound annual growth rate of 9.7% through the forecasted period. This upward trajectory is primarily fueled by an increasing elderly demographic, a higher incidence of long-term health conditions, a greater need for nutritional support via parenteral routes, the development of healthcare facilities in developing economies, and an increased provision of emergency and trauma medical services. Key developments shaping this market in the coming years include a surge in preference for environmentally friendly and PVC-free LVP containers, a greater availability of pre-prepared and mixed infusion products, an intensified emphasis on maintaining sterile conditions and preventing contamination, a broader application of LVPs in critical care settings and emergency medicine, and an overall increase in the volume of intravenous therapies administered within hospitals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Large Volume Parenteral (LVP) Market Expansion Supported By Key Demand Factors

The escalating incidence of long-term illnesses is anticipated to be a significant catalyst for the expansion of the large-volume parenteral market in the future. Chronic diseases, characterized by conditions persisting for three months or more and potentially progressing over time, are largely attributed to factors such as tobacco consumption, exposure to secondhand smoke, and inadequate dietary habits. Patients suffering from these ailments necessitate a balanced intake of vital nutrients essential for maintaining bodily strength, and parenteral administration proves advantageous by ensuring direct absorption of pharmaceutical dosages into the bloodstream, bypassing the digestive tract. Illustratively, the World Health Organization reported in September 2023 that non-communicable diseases, or chronic conditions, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Consequently, the increased prevalence of chronic diseases serves as a primary driver for the growth observed in the large-volume parenteral market.

Augmenting healthcare spending is projected to significantly boost the large-volume parenteral market in the coming period. This increase in financial investment towards healthcare encompasses a broader allocation of resources for medical services, research, and public health initiatives. Enhanced financial commitment often correlates with the development and fortification of healthcare infrastructure, including the establishment of new medical centers and facilities, thereby increasing the capacity for service delivery and consequently stimulating the demand for large-volume parenteral products. As an example, the American Medical Association indicated in April 2025 that US healthcare spending experienced a substantial rise of 7.5% in 2023, reaching $4.9 trillion or $14,570 per individual, a notable uptick from the 4.6% growth noted in the preceding year. Hence, the upward trend in healthcare expenditure is a key factor propelling the expansion of the large-volume parenteral market.

Large Volume Parenteral (LVP) Market Segment Landscape And Growth Potential

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Large Volume Parenteral (LVP) Market Growth Trends Influencing Competitive Dynamics

Global leaders in the large volume parenteral (LVP) market are prioritizing the creation of smart infusion device advancements, specifically intelligent large-volume infusion pumps, to address the growing need for enhanced safety, automation, and connectivity in intravenous therapy. This trend is fueled by the expansion of hospital-based infusion services, the rise of remote patient monitoring, and the industry-wide drive for standardized, error-minimizing medication administration. An intelligent large-volume infusion pump distinguishes itself from conventional devices by incorporating dose-error reduction software, smart drug library capabilities, and advanced alarm management, going beyond the manual programming and basic automation of older models. These sophisticated pumps are engineered to deliver substantial IV fluid volumes while actively preventing medication errors, easing healthcare professionals’ workloads, and seamlessly integrating with hospital information technology infrastructures. As a prime example, Baxter International Inc. secured U.S. FDA approval in April 2024 for its Novum IQ Large-Volume Infusion Pump, featuring the integrated Dose IQ smart-dose software. This innovative pump facilitates rapid fluid delivery, including extensive volume infusions, and boasts safety mechanisms like drug library integration to mitigate dosing inaccuracies, alongside the capability to link with hospital electronic health records and intelligent monitoring systems, ultimately empowering clinicians to enhance infusion precision, diminish the likelihood of dosage errors, and optimize workflows for high-volume IV therapies, ensuring safer and more efficient patient care.

Large Volume Parenteral (LVP) Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Access The Complete Large Volume Parenteral (LVP) Market Report:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Large Volume Parenteral (LVP) Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Large Volume Parenteral (LVP) Market Size, Value And Growth Trends Through 2030

The global market for large volume parenteral (LVP) solutions has experienced robust expansion lately. Projections indicate this sector will expand from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate of 9.1%. Key factors contributing to this growth during the preceding period include an upward trend in hospital admissions, increased reliance on intravenous fluid therapies, a rise in the number of surgical interventions, enhancements in critical care facilities, and advancements in managing infectious diseases.

The global market for large volume parenteral (LVP) solutions is poised for significant expansion, projected to reach $21.37 billion by the year 2030, registering a compound annual growth rate of 9.7% through the forecasted period. This upward trajectory is primarily fueled by an increasing elderly demographic, a higher incidence of long-term health conditions, a greater need for nutritional support via parenteral routes, the development of healthcare facilities in developing economies, and an increased provision of emergency and trauma medical services. Key developments shaping this market in the coming years include a surge in preference for environmentally friendly and PVC-free LVP containers, a greater availability of pre-prepared and mixed infusion products, an intensified emphasis on maintaining sterile conditions and preventing contamination, a broader application of LVPs in critical care settings and emergency medicine, and an overall increase in the volume of intravenous therapies administered within hospitals.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Large Volume Parenteral (LVP) Market Expansion Supported By Key Demand Factors

The escalating incidence of long-term illnesses is anticipated to be a significant catalyst for the expansion of the large-volume parenteral market in the future. Chronic diseases, characterized by conditions persisting for three months or more and potentially progressing over time, are largely attributed to factors such as tobacco consumption, exposure to secondhand smoke, and inadequate dietary habits. Patients suffering from these ailments necessitate a balanced intake of vital nutrients essential for maintaining bodily strength, and parenteral administration proves advantageous by ensuring direct absorption of pharmaceutical dosages into the bloodstream, bypassing the digestive tract. Illustratively, the World Health Organization reported in September 2023 that non-communicable diseases, or chronic conditions, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Consequently, the increased prevalence of chronic diseases serves as a primary driver for the growth observed in the large-volume parenteral market.

Augmenting healthcare spending is projected to significantly boost the large-volume parenteral market in the coming period. This increase in financial investment towards healthcare encompasses a broader allocation of resources for medical services, research, and public health initiatives. Enhanced financial commitment often correlates with the development and fortification of healthcare infrastructure, including the establishment of new medical centers and facilities, thereby increasing the capacity for service delivery and consequently stimulating the demand for large-volume parenteral products. As an example, the American Medical Association indicated in April 2025 that US healthcare spending experienced a substantial rise of 7.5% in 2023, reaching $4.9 trillion or $14,570 per individual, a notable uptick from the 4.6% growth noted in the preceding year. Hence, the upward trend in healthcare expenditure is a key factor propelling the expansion of the large-volume parenteral market.

Large Volume Parenteral (LVP) Market Segment Landscape And Growth Potential

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Large Volume Parenteral (LVP) Market Growth Trends Influencing Competitive Dynamics

Global leaders in the large volume parenteral (LVP) market are prioritizing the creation of smart infusion device advancements, specifically intelligent large-volume infusion pumps, to address the growing need for enhanced safety, automation, and connectivity in intravenous therapy. This trend is fueled by the expansion of hospital-based infusion services, the rise of remote patient monitoring, and the industry-wide drive for standardized, error-minimizing medication administration. An intelligent large-volume infusion pump distinguishes itself from conventional devices by incorporating dose-error reduction software, smart drug library capabilities, and advanced alarm management, going beyond the manual programming and basic automation of older models. These sophisticated pumps are engineered to deliver substantial IV fluid volumes while actively preventing medication errors, easing healthcare professionals’ workloads, and seamlessly integrating with hospital information technology infrastructures. As a prime example, Baxter International Inc. secured U.S. FDA approval in April 2024 for its Novum IQ Large-Volume Infusion Pump, featuring the integrated Dose IQ smart-dose software. This innovative pump facilitates rapid fluid delivery, including extensive volume infusions, and boasts safety mechanisms like drug library integration to mitigate dosing inaccuracies, alongside the capability to link with hospital electronic health records and intelligent monitoring systems, ultimately empowering clinicians to enhance infusion precision, diminish the likelihood of dosage errors, and optimize workflows for high-volume IV therapies, ensuring safer and more efficient patient care.

Large Volume Parenteral (LVP) Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Access The Complete Large Volume Parenteral (LVP) Market Report:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Large Volume Parenteral (LVP) Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Large Volume Parenteral (LVP) Market Compare Between 2026 And 2030?

The large volume parenteral (lvp) market size has demonstrated robust expansion over recent years. Forecasts indicate it will expand from $13.53 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Historically, this growth was driven by factors such as increasing hospitalization rates, a rise in intravenous fluid therapy usage, more surgical procedures, the broadening of critical care infrastructure, and the increase in infectious disease treatment.

The large volume parenteral (lvp) market is anticipated to experience robust expansion over the coming years. It is projected to reach $21.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period can be attributed to factors such as an expanding aging population, the increasing incidence of chronic diseases, a greater need for parenteral nutrition, the development of healthcare infrastructure in new markets, and an uptick in emergency and trauma care services. Key trends expected during this period involve a heightened demand for non-pvc and environmentally friendly lvp packaging, the proliferation of ready-to-use and premixed infusion solutions, a sharper emphasis on sterility and preventing contamination, the increasing application of lvps in critical care and emergency medicine, and a rise in the volume of hospital-based infusion therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

Which Key Drivers Are Affecting The Large Volume Parenteral (LVP) Market Development?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the large-volume parenteral market going forward. Chronic diseases are long-term health issues or conditions, usually persisting for three months or more, with the potential for deterioration. Factors contributing significantly to the increase in chronic diseases include tobacco consumption, exposure to smoke, and inadequate nutrition. Patients with such conditions necessitate a balanced intake of vital nutrients to maintain vigor. The parenteral administration method ensures precise drug dosing as the majority of the medication enters circulation directly, bypassing the digestive system. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Consequently, the rising prevalence of chronic diseases is a key factor propelling the expansion of the large-volume parenteral market.

Which Segment Types Are Examined In The Large Volume Parenteral (LVP) Market Segment Study?

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

What Trends Are Transforming The Large Volume Parenteral (LVP) Market?

Major companies operating within the Large Volume Parenteral (LVP) market are prioritizing the development of innovative smart infusion devices, such as intelligent large-volume infusion pumps. This focus addresses the increasing demand for safer, more automated, and connected intravenous therapy, driven by the expansion of hospital-based infusion services, remote patient monitoring, and the drive towards standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is engineered to deliver high-volume IV fluids (LVP) and incorporates dose-error reduction software, connectivity for smart drug libraries, and alarm management. Unlike traditional infusion pumps, which rely purely on manual programming and limited automation, these next-generation pumps aid in preventing dosing mistakes, reducing workflow burden, and integrating with hospital IT systems. As an illustration, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical-device company, obtained U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump, equipped with Dose IQ smart-dose software. This device supports high-rate fluid delivery, including large-volume infusions, offers safety features like drug library integration to minimize dosing errors, and enables connectivity to hospital electronic medical records and smart monitoring platforms. By facilitating the safe, automated, and reliable infusion of large volumes, the Novum IQ pump empowers healthcare providers to improve infusion accuracy, decrease the risk of dosing errors, and streamline high-volume IV therapy workflows.

Which Players Are Part Of The Competitive Landscape Of The Large Volume Parenteral (LVP) Market?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Get The Full Large Volume Parenteral (LVP) Market Report:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Which Geographic Region Dominates The Large Volume Parenteral (LVP) Market?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Large Volume Parenteral (LVP) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Browse Through More Reports Similar to the Global Large Volume Parenteral (LVP) Market 2026, By The Business Research Company

Small Volume Parenteral Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Small Volume Parenteral Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Parenteral Nutrition Market Report

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Large Volume Parenteral (LVP) Market Evolve From 2026 To 2030?

The large volume parenteral (lvp) market size has shown strong growth over recent years. It is anticipated to increase from $13.53 billion in 2025 to $14.76 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. The expansion observed historically is attributable to factors such as rising hospitalization rates, an increase in intravenous fluid therapy usage, more frequent surgical procedures, the development of critical care infrastructure, and the growth in infectious disease treatment.

The large volume parenteral (lvp) market is anticipated to experience robust expansion over the coming years. Projections indicate it will reach $21.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is primarily driven by factors such as an aging global population, the escalating occurrence of chronic illnesses, a heightened need for parenteral nutrition, the development of healthcare infrastructure in developing economies, and an increase in emergency and trauma care provisions. Key trends anticipated during this period encompass a rising preference for non-PVC and environmentally friendly LVP packaging, the proliferation of pre-prepared and pre-mixed infusion solutions, an intensified emphasis on ensuring sterility and preventing contamination, the expanding application of LVPs in critical care and emergency medical settings, and an increase in the volume of hospital-based infusion therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp

What Drivers Are Influencing The Large Volume Parenteral (LVP) Market?

The increasing incidence of long-term health conditions is projected to boost the expansion of the large-volume parenteral market in the future. These conditions are defined as illnesses or health issues that typically persist for at least three months and may deteriorate over time. The escalation in chronic disease cases is primarily attributed to factors such as tobacco consumption, exposure to smoke, and inadequate nutrition. Patients suffering from these conditions necessitate a suitable balance of vital nutrients to sustain their strength. Parenteral administration ensures precise drug dosages, as most medications are absorbed directly into the bloodstream, bypassing the digestive system. For example, data from September 2023, provided by the World Health Organization, a specialized United Nations agency based in Switzerland, indicated that 41 million deaths annually worldwide, representing 74% of all fatalities, were due to non-communicable diseases (NCDs) or chronic conditions. Consequently, the rising prevalence of chronic diseases is a key factor propelling the expansion of the large-volume parenteral market.

Which Segment Areas Are Covered In The Large Volume Parenteral (LVP) Market Analysis?

The large volume parenteral (lvp) market covered in this report is segmented –

1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP

2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More

3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion

4) By End-User: Hospital, Medical Centers, Other End Users

Subsegments:

1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags

2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags

3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles

Which Trends Are Shaping The Future Of The Large Volume Parenteral (LVP) Market?

Leading companies in the large volume parenteral (LVP) market are focusing on developing smart infusion device innovations, such as intelligent large-volume infusion pumps. This approach aims to meet the growing demand for safer, more automated, and connected intravenous therapy, driven by the expansion of hospital-based infusion services, remote patient monitoring, and the need for standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is designed to deliver high-volume IV fluids (LVP) and includes dose-error reduction software, connectivity to smart drug libraries, and advanced alarm management features. Unlike conventional infusion pumps that depend on manual programming and offer limited automation, these advanced systems help reduce dosing errors, ease workflow burdens, and integrate seamlessly with hospital IT infrastructure. For example, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical device company, received U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump with Dose IQ smart-dose software. This device enables high-rate fluid delivery, including large-volume infusions, incorporates safety features such as drug library integration to minimize dosing errors, and supports connectivity with hospital electronic medical records and smart monitoring systems. By enabling safe, automated, and reliable administration of large fluid volumes, the Novum IQ pump helps healthcare providers improve infusion accuracy, reduce the risk of dosing errors, and streamline high-volume IV therapy processes.

Which Global Companies Are Actively Competing In The Large Volume Parenteral (LVP) Market?

Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare

Read the full large volume parenteral (lvp) market report here:

https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Large Volume Parenteral (LVP) Market?

North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Large Volume Parenteral (LVP) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp

Browse Through More Reports Similar to the Global Large Volume Parenteral (LVP) Market 2026, By The Business Research Company

Small Volume Parenteral Global Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Small Volume Parenteral Global Market Report

https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

Parenteral Nutrition Global Market Report

https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model